21 March 2018 - - Martinez, California-based blood filtration devices specialist ExThera Medical Corp. plans to create ExThera Medical Europe, and has appointed Carla Kikken-Jussen as managing director of the new wholly-owned subsidiary.
Kikken-Jussen brings more than 30 years of experience in clinical research and the commercialization of new medical devices in the European market to ExThera Medical, where she will oversee the strategic direction for ExThera's European operations.
She was most recently interim CEO and board chairwoman of Vimecon GmbH, which provides laser-based treatment of atrial fibrillation. In 2000, she founded MediTech Strategic Consultants in the Netherlands, a contract research organization for medical devices, and served as the company's CEO until the company was acquired by MedPace in 2012.
ExThera Medical is a privately held medical device company developing innovative, single-use blood filters capable of capturing and removing a broad range of bacteria, viruses, parasites, toxins, or other harmful substances from whole blood.
The company develops therapeutic products to treat patients in the field or hospital, and devices that can purify transfused blood prophylactically.